Ignite Creation Date:
2024-07-17 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06467981
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-06-11
Brief Title:
Study of the Indications for Amyloid Positon Emission Tomography PET Scans and Their Usefulness for Patients With Suspected Alzheimers Disease AD
Sponsor:
Central Hospital Nancy France
Organization:
Central Hospital Nancy France
Study Overview
Official Title:
Study of the Indications for Amyloid PET Scans and Their Usefulness in the Management of Patients With Suspected Alzheimers Disease AD
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TEPAmy
Brief Summary:
The recent clinical authorization of amyloid Positon Emission Tomography PET in France represents a crucial step for the nuclear medicine community involved in the diagnosis of Alzheimers disease AD
Detailed Description:
The recent clinical authorization of amyloid Positon Emission Tomography PET in France represents a crucial step for the nuclear medicine community involved in the diagnosis of Alzheimers disease AD At the era of Amyloid Tau Neurodegeneration ATN biomarkers amyloid PET fills a need in patients with an atypical or mixed clinical presentation in particular young patients 65 years old when the lumbar puncture is contraindicated or not feasible for technical reasons Importantly a negative amyloid PET scan discards the diagnosis of AD Furthermore early phase imaging of amyloid PET allows to estimate the perfusion neuronal state increasing the diagnostic value of such PET radiotracer Its role could be further developed in routine care for the selection and monitoring of promising disease modifiers therapies
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None